小细胞肺癌

National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. 2016. http://www.nccn.org (last accessed 30 August 2016).

• 全文

Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618-1624.

• 摘要

Fried DB, Morris DE, Poole C, et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol. 2004;22:4837-4845.

• 摘要

Slotman BJ, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet. 2015;385:36-42.

• 全文
• 摘要

1.  Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J. 2001;18:1059-1068.

• 全文
• 摘要

2.  US Public Health Service. Smoking and health. Report of the Advisory Committee to the Surgeon General of the Public Health Service. PHS Publication no. 1103. Washington, DC: US Government Printing Office; 1964.

3.  Beckles MA, Spiro SG, Colice GL, et al. Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest. 2003;123(1 suppl):97S-104S.

• 摘要

4.  Wudel LJ, Nesbitt JC. Superior vena cava syndrome. Curr Treat Options Oncol. 2001;2:77-91.

• 摘要

5.  National Institute for Health and Care Excellence. Lung cancer: diagnosis and management. CG121. April 2011. http://www.nice.org.uk (last accessed 30 August 2016).

• 全文

6.  American Cancer Society. Cancer Facts & Figures 2015. 2015. http://www.cancer.org/ (last accessed 30 August 2016).

• 全文

7.  Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130.

• 全文
• 摘要

8.  Stat bite: Mortality from lung and bronchus cancer by race/ethnicity, 1998-2002. J Natl Cancer Inst. 2006;98:158.

• 摘要

9.  Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.

• 全文
• 摘要

10.  Doll R, Hill D. Smoking and carcinoma of the lung; a preliminary report. BMJ. 1950;2:739-748.

• 摘要

11.  Levin ML, Goldstein H, Gerhardt PR. Cancer and tobacco smoking; a preliminary report. JAMA. 1950;143:336-338.

• 摘要

12.  Wynder EL, Graham EA. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma; a study of six hundred and eighty-four proved cases. JAMA. 1950;143:329-336.

• 摘要

13.  Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(suppl 1):21S-49S.

• 摘要

14.  Shields PG. Molecular epidemiology of smoking and lung cancer. Oncogene. 2002;21:6870-6876.

• 摘要

15.  Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol. 2006;24:4539-4544.

• 全文
• 摘要

16.  National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: small cell lung cancer. 2016. http://www.nccn.org (last accessed 30 August 2016).

• 全文

17.  Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ. 1997;315:980-988.

• 摘要

18.  Darby S, Hill D, Auvinen A, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. BMJ. 2005;330:223.

• 全文
• 摘要

19.  Zielinski JM, Carr Z, Krewski D, et al. World Health Organization's International Radon Project. J Toxicol Environ Health A. 2006;69:759-769.

• 摘要

20.  Omenn GS, Merchant J, Boatman E, et al. Contribution of environmental fibers to respiratory cancer. Environ Health Perspect. 1986;70:51-56.

• 全文
• 摘要

21.  Hessel PA, Gamble JF, McDonald JC. Asbestos, asbestosis, and lung cancer: a critical assessment of the epidemiological evidence. Thorax. 2005;60:433-436.

• 摘要

22.  Leone FT, Evers-Casey S, Toll BA, et al. Treatment of tobacco use in lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(suppl 5):e61S-e77S.

• 摘要

23.  Merchut MP. Brain metastases from undiagnosed systemic neoplasms. Arch Intern Med. 1989;149:1076-1080.

• 摘要

24.  Miller KL, Shafman TD, Marks LB. A practical approach to pulmonary risk assessment in the radiotherapy of lung cancer. Semin Radiat Oncol. 2004;14:298-307.

• 摘要

25.  Beckles MA, Spiro SG, Colice GL, et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest. 2003;123(1 suppl):105S-114S.

• 摘要

26.  Schottenfeld D, Searle JG. The etiology and epidemiology of lung cancer. In: Pass HI, Carbone DP, Johnson DH, et al., eds. Lung cancer - principles and practice. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:3.

27.  Galluzzi S, Payne PM. Bronchial carcinoma: a statistical study of 741 necropsies with special reference to the distribution of blood-borne metastases. Br J Cancer. 1955;9:511-527.

• 摘要

28.  Alexopoulos CG, Vaslamatzis M, Patila E, et al. Central nervous system involvement and the role of prophylactic cranial irradiation in small cell lung cancer. Oncologist. 1997;2:153-159.

• 全文
• 摘要

29.  Rosen ST, Makuch RW, Lichter AS, et al. Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer. Potential benefit restricted to patients with complete response. Am J Med. 1983;74:615-624.

• 摘要

30.  Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst. 1996;88:1210-1215.

• 全文
• 摘要

31.  Sause W, Kolesar P, Taylor S IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest. 2000;117:358-364.

• 摘要

32.  Simon GR, Wagner H; American College of Chest Physicians. Small cell lung cancer. Chest. 2003;123(1 suppl):259S-271S.

• 全文
• 摘要

33.  Rosa UW, Prolla JC, Gastal E da S. Cytology in diagnosis of cancer affecting the lung: results in 1,000 consecutive patients. Chest. 1973;63:203-207.

• 全文
• 摘要

34.  Savage PJ, Donovan WN, Dellinger RP. Sputum cytology in the management of patients with lung cancer. South Med J. 1984;77:840-842.

• 摘要

35.  Pastis NJ, Silvestri GA. Tissue procurement: bronchoscopic techniques. In: Pass HI, Carbone DP, Johnson DE, et al., eds. Lung cancer - principles and practice. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:358-371.

36.  Steinfort DP, Khor YH, Manser RL, et al. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. Eur Respir J. 2011;37:902-910.

• 摘要

37.  Edge SB, Byrd DR, Compton CC, et al, eds. AJCC cancer staging manual. 7th ed. New York, NY: Springer-Verlag, 2010.

38.  Aberle DR, Adams AM, Berg CD, et al; National Lung Screening Trial Research Team. Reduced lung cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.

• 全文
• 摘要

39.  Pignon JP, Arriagada R, Ihde DC, et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992;327:1618-1624.

• 摘要

40.  Fried DB, Morris DE, Poole C, et al. Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer. J Clin Oncol. 2004;22:4837-4845.

• 摘要

41.  Turrisi AT 3rd, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med. 1999;340:265-271.

• 全文
• 摘要

42.  Auperin A, Arriagada R, Pignon JP, et al; Prophylactic Cranial Irradiation Overview Collaborative Group. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. N Engl J Med. 1999;341:476-484.

• 全文
• 摘要

43.  National Cancer Institute/Radiation Therapy Oncology Group. Three different radiation therapy regimens in treating patients with limited-stage small cell lung cancer receiving cisplatin and etoposide: NCT00632853. http://www.clinicaltrials.gov (last accessed 30 August 2016).

• 全文

44.  Pelayo Alvarez M, Westeel V, Cortés-Jofré M, et al. Chemotherapy versus best supportive care for extensive small cell lung cancer. Cochrane Database Syst Rev. 2013;(11):CD001990.

• 全文
• 摘要

45.  Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol. 1999;17:2092-2099.

• 摘要

46.  Slotman BJ, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial. Lancet. 2015;385:36-42.

• 全文
• 摘要

47.  Slotman B, Faivre-Finn C, Kramer G, et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med. 2007;357:664-672

• 全文
• 摘要

48.  Seto T, Takahashi T, Yamanaka T, et al. Prophylactic cranial irradiation (PCI) has a detrimental effect on the overall survival (OS) of patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Results of a Japanese randomized phase III trial. 2014 ASCO Annual Meeting Abstracts. J Clin Oncol. 2014;32(15 suppl):7503.

• 全文

49.  Le Péchoux C, Dunant A, Senan S, et al. Prophylactic Cranial Irradiation (PCI) Collaborative Group. Standard-dose versus higher-dose prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy: a randomised clinical trial. Lancet Oncol. 2009;10:467-474.

• 摘要

50.  Le Péchoux C, Laplanche A, Faivre-Finn C, et al; Prophylactic Cranial Irradiation (PCI) Collaborative Group. Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01). Ann Oncol. 2011;22:1154-1163.

• 全文
• 摘要

51.  Miller KL, Shafman TD, Anscher MS, et al. Bronchial stenosis: an underreported complication of high-dose external beam radiotherapy for lung cancer? Int J Radiat Oncol Biol Phys. 2005;61:64-69.

• 摘要

52.  Socinski MA, Morris DE, Halle JS, et al. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial. J Clin Oncol. 2004;22:4341-4350.

• 摘要

53.  Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol. 1993;11:336-344.

• 摘要

54.  Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol. 2002;20:3054-3060.

• 摘要

55.  Hanna N, Bunn PA, Jr., Langer C, et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol. 2006;24:2038-2043.

• 全文
• 摘要

56.  Noda K, Nishiwaki Y, Kawahara M, et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med. 2002;346:85-91.

• 全文
• 摘要

57.  Pujol JL, Douillard JY, Rivière A, et al. Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study. J Clin Oncol. 1997;15:2082-2089.

• 摘要

58.  Bunn PA Jr, Crowley J, Kelly K, et al. Chemoradiotherapy with or without granulocyte-macrophage colony-stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol. 1995;13:1632-1641. [Erratum in: J Clin Oncol. 1995;13:2860.]

• 摘要

59.  Werner-Wasik M, Yorke E, Deasy J, et al. Radiation dose-volume effects in the esophagus. Int J Radiat Biol Phys. 2010;76(3 Suppl):S86-S93.

• 摘要

60.  Ghafoori P, Kelsey CR, Marks LB, et al. Radiation-induced lung injury. Assessment, management, and prevention. Oncology. 2008;37:37-47.

• 摘要

61.  Parsons A, Daley A, Begh R, et al. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569.

• 全文
• 摘要

62.  Chen J, Jiang R, Garces YI, et al. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer. 2010;67:221-226.

• 摘要